See all posts tagged: "Drug"

img
SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic causes of cancer, today announced that TPX-0022, the inhibitor of MET and its associated cancer signaling pathways of SRC and CSF1R,...
1 2 37

Above are the posts tagged "Drug"

View Publication by Topic

(***)

(***)

Tags: ADVANCED LUNG CANCER TREATMENT PROGNOSIS, ADVANCED LUNG CANCER TREATMENT SIDE EFFECTS, ADVANCES IN LUNG CANCER TREATMENT, ANY NEW TREATMENTS FOR SMALL CELL LUNG CANCER

Thank You For Reading our "Drug" Tag Page. Please bookmark this page and check back often to keep up-to-date with our latest news.

This div height required for enabling the sticky sidebar